US Drug Approval A040843

Methotrexate Sodium Preservative Free  Jan 11, 2010

4 approved drug products.
Methotrexate Sodium Preservative Free
  • Ingredients: Methotrexate Sodium;
  • Dosage form: injectable;
  • Route of administration: injection;
  • Strength: eq 1gm base/40ml (eq 25mg base/ml);
  • Approval date: January 11, 2010;
  • Marketing status: prescription.
Methotrexate Sodium Preservative Free
  • Ingredients: Methotrexate Sodium;
  • Dosage form: injectable;
  • Route of administration: injection;
  • Strength: eq 50mg base/2ml (eq 25mg base/ml);
  • Approval date: January 11, 2010;
  • Marketing status: prescription.
Methotrexate Sodium Preservative Free
  • Ingredients: Methotrexate Sodium;
  • Dosage form: injectable;
  • Route of administration: injection;
  • Strength: eq 100mg base/4ml (eq 25mg base/ml);
  • Approval date: February 27, 2012;
  • Marketing status: prescription.
Methotrexate Sodium Preservative Free
  • Ingredients: Methotrexate Sodium;
  • Dosage form: injectable;
  • Route of administration: injection;
  • Strength: eq 250mg base/10ml (eq 25mg base/ml);
  • Approval date: January 11, 2010;
  • Marketing status: prescription.

Parties

Applicants
Countries
US

JSON preview

Similar records

Title

Source:  FDA Last updated:  Jun 5, 2019

From the Orange Book, a publication of the U.S. Food and Drug Administration. This record may not reflect the most current and accurate biomedical/scientific data available from the FDA.